Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.15 - $0.22 $62,169 - $91,181
-414,462 Reduced 13.87%
2,573,819 $514,000
Q3 2023

Nov 13, 2023

BUY
$0.16 - $0.23 $6,140 - $8,827
38,380 Added 1.3%
2,988,281 $508,000
Q2 2023

Aug 10, 2023

BUY
$0.19 - $0.22 $155,640 - $180,215
819,163 Added 38.45%
2,949,901 $589,000
Q1 2023

May 11, 2023

BUY
$0.16 - $0.29 $340,918 - $617,914
2,130,738 New
2,130,738 $447,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.